Pharma.Aero inks MoU with IATA to support the CEIV pharma industry standard
March 22, 2018: Pharma.Aero signed a memorandum of understanding (MoU) with IATA, at the recently held World Cargo Symposium in Dallas, US.
Nathan De Valck, chairman, Pharma.Aero said: “Formalising the MoU with IATA is an important milestone. It will allow to upscale our initiatives, and enroll projects within a larger international platform in the life science airfreight industry. The MoU underlines our vision to foster collaboration with air cargo stakeholders that support the CEIV pharma industry standard.”
“IATA CEIV Pharma certification provide tools and means to all players in the air cargo value chain, to ensure that they meet the highest standards, while handling and transporting life-saving drugs. The MoU between Pharma.aero and IATA will help in formalising an ongoing collaboration between two organisations, with an aim to offer better assistance to the industry, and improve the quality of services for the pharmaceutical handling and transportation in the air cargo industry, globally,” said Glyn Hughes, global head of cargo, IATA.
Frank Van Gelder, secretary general, Pharma.Aero said: “The MoU will mutually benefit for both IATA and Pharma.Aero. The members of Pharma.Aero will focus on creating content, and become a reference for various pharmaceutical companies and operators, within the life science airfreight industry. We are convinced that this MoU will boost our initiatives and projects, which are in the pipeline.”